Aditi Mehta

1.1k citations
60 papers · 670 indexed · h-index 10
Topics
Chronic Lymphocytic Leukemia Research (9 papers)Viral-associated cancers and disorders (8 papers)Facial Trauma and Fracture Management (6 papers)

In The Last Decade

Aditi Mehta

51 papers receiving 660 citations

Peers

Aditi Mehta
Comparison fields: 5 of 90
  • Molecular Biology 359
  • Cancer Research 135
  • Ophthalmology 133
  • Oncology 127
  • Radiology, Nuclear Medicine and Imaging 85
Replace Tapan Ganguly with:
Tapan Ganguly United States
Anita S. Bowman United States
Junna Oba Japan
Monika Anand United States
Xinzheng V. Guo United States
Jiehao Zhou United States
Joanne Sutherland Canada
Francesco Lanza Italy
Shiqi Ling China
Monica Gerber United States
Aditi Mehta relative to Tapan Ganguly United States Tapan Ganguly's profile →
Citations per field
00.5×2.6×
Tapan Ganguly · 1×
Citations per year

Countries citing papers authored by Aditi Mehta

Since Specialization
Citations

This map shows the geographic impact of Aditi Mehta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aditi Mehta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aditi Mehta more than expected).

Fields of papers citing papers by Aditi Mehta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aditi Mehta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aditi Mehta. The network helps show where Aditi Mehta may publish in the future.

Co-authorship network of co-authors of Aditi Mehta

This figure shows the co-authorship network connecting the top 25 collaborators of Aditi Mehta. A scholar is included among the top collaborators of Aditi Mehta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aditi Mehta. Aditi Mehta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 8
4 35
5 9
6 1
7 0
8 1
9 1
10 6
11 6
12 1
13 30
14 2
15 4
16 7
17 1
18 72
19 47
20 112

About Aditi Mehta

Aditi Mehta is a scholar working on Ophthalmology, Genetics and Pathology and Forensic Medicine, having authored 60 papers that have together received 670 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (9 papers), Viral-associated cancers and disorders (8 papers) and Facial Trauma and Fracture Management (6 papers). The work is most often cited by research in Ophthalmology (133 citations), Cancer Research (135 citations) and Molecular Biology (359 citations). Aditi Mehta has collaborated with scholars based in India, United States and Germany. Frequent co-authors include Guillermo Barreto, Stephanie Dobersch, Thomas Braun, Indrabahadur Singh, Gianni Carraro, Werner Seeger, Savério Bellusci, Viney Gupta, Keith R. Martin and Algis J. Vingrys. Their work appears in journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026